Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Gastrointest Endosc. 2020 Jun 19;93(2):409–419.e1. doi: 10.1016/j.gie.2020.06.032

Table 3.

Multivariate odds ratios and 95% confidence intervals (CI) for odds of Barrett’s esophagus (BE) in the primary care population and asymptomatic patients only as well as odds of GERD symptoms or PPI use in all BE cases.

All Cases and Controls Asymptomatic Cases and Controls All Cases*
OR (95% CI) OR (95% CI) OR (95% CI)
Age (ref: < 60 years) 1.06 (0.52–2.17) 0.83 (0.32–2.13) 0.83 (0.19–3.62)
Race (ref: African-American)
 Non-Hispanic white 3.25 (1.36–7.77) 5.65 (1.59–20.10) 1.32 (0.15–11.79)
 Hispanic 3.41 (1.09–10.66) 6.39 (1.32–30.98) 2.01 (0.18–22.14)
GERD Presence/Duration (ref: no GERD)
 < 5 years 4.44 (0.39–50.50) --- ---
 ≥ 5 years 1.95 (1.01–3.78) --- ---
Smoking Status (ref: never smoker)
 Former Smoker 0.93 (0.40–2.13) 1.19 (0.39–3.62) 0.39 (0.05–3.01)
 Current Smoker 1.28 (0.53–3.12) 1.57 (0.48–5.10) 0.67 (0.07–6.24)
WHR (ref: 1st tertile)
 2nd Tertile 1.89 (0.77–4.59) 1.67 (0.54–5.15) 0.69 (0.15–3.16)
 3rd Tertile 2.22 (0.91–5.41) 1.68 (0.53–5.31) 1.60 (0.34–7.48)
*

Odds of having GERD symptoms or PPI use